We surveyed the 10-yr mortality among 152 Behcet's syndrome (BS) patients who had registered at a BS out-patient clinic and compared it to the expected mortality in the general population. Information on mortality was available in 79% of the study group, among whom six patients (all male) had died. The observed mortality of two patients in the 15-24 yr age bracket was significantly above that expected in the general population. BS is a cause of increased mortality in the young male patients. KEY WORDS: Mortahty, Behcet's syndrome, Prognosis, Male.
PATIENTS AND METHODS
All new patients who had registered in our multidisciplinary Behcet's out-patient clinic between 1982 and 1983 were called back within the second half of 1993. Those patients who were seen within the past 6 months in 1993 were considered as still attending. The remainder were traced by letter, telephone and, if necessary, by site visits. Attained mortality data were compared with expected values derived from three different mortality tables. These were the 1986-1990 Turkish Mortahty table prepared by M. L. Duransoy as a Ph.D. thesis, the American CSO (Commissioner's Standard and Ordinary Mortality Table) 1953-1958 and the German ADST (die allgemeine Deutsche statistische Tafel) 1944-51 [3] . A mortality table gives the risk of death at each age of the population under study. From these tables, we can calculate the probability of a person now aged x living n more years by:
where l x is the number of people alive at age x and l x+m is the number of people alive at age x+n. The corresponding probability of death in n years is given by: For the purposes of this study, we chose a 10-yr horizon for mortality by calculating the probability of a person aged x dying within 10 yr, for all ages (age of registration at the clinic) in our group. Age brackets were designed so that there would be at least one death in each age bracket according to our data. The death rate probability in 10 yr corresponding to each age bracket was calculated as the mean of the 10-yr death probabilities of those in that particular age bracket. In comparing these expected values with mortality data from the group under study, one-sided confidence intervals were set for a = 0.05 and a = 0.01 by E^z + Zfi x where E x is the number of Behcet patients in the age bracket, q x is the theoretical probability of death and G x is SJ5.
The analyses were carried out only for males since there were no female deaths recorded. No formal statistics were done for the data in Table II since the number of patients in group II (those that died) was quite small.
RESULTS
One hundred and fifty-two new patients (92 males and 60 females) were registered in our clinic between 1982 and 1983. Thirty-five were still attending and, according to the records, a further five had died. Attempts were made to reach the remaining 112. Seventy-nine could be reached and 29 of these came to the clinic for re-evaluation. An additional patient was found to have died and finally no information was available on 32 (21%) of the patients. Of these 32 patients lost to follow-up, 17 were male and 15 female. There were four male patients and one female patient lost to follow-up in the 15-24yr age bracket. Table I shows the upper limits of the expected number of deaths in 10 yr for 95 and 99% confidence limits. It is seen that for the age bracket 15-24, the observed number of two deaths was above both the 95 and 99% limits for all three mortahty tables utilized. When we looked at the same age bracket, assuming the t distribution instead of the z utilized in the table (data not given), the results remained robust.
© 1996 British Society for Rheumatology 139 We further assumed that all four male patients who were lost to follow-up in the 15-24 age bracket remained alive (E x = 20), and calculated the expected number of deaths for 95 and 99% limits according to the Turkish Mortality table. The maximum numbers of deaths thus calculated were 1.32 for the 95% and 1.71 for the 99% limits. These were still less than the two observed. We also compared the disease severity among those male patients on whom information other than death was available, those that died and those that were lost to follow-up. This was done by comparing within the three groups the disease duration and the prevalences of eye, vascular and neurological involvement (Table II) . It is to be noted that those patients who eventually died tended to have more severe disease at the time of presentation. Among the 16 male patients in the youngest (15-24) age bracket at the time of presentation, four were lost to follow-up. Of these four patients, three had eye and none had vascular or neurological disease at the time of presentation. This compared with eight patients with eye, three with vascular and one with neurological disease among the 12 patients in the same age bracket in whom outcome information including death was available. The disease duration between these two groups was also similar. Table III summarizes the definite or probable causes of death in six patients. Four patients had PAA and of those MS and AM died as a direct result of PAA. MS died with a severe haemoptysis within a few weeks of an operation for PAA. AM died with abundant haemoptysis without being operated on. HC had superior vena caval syndrome and recurrent haemoptysis due to PAA. His immediate family were not sure of the terminating event. YO had inferior vena caval thrombosis when he first saw us. We learned that he died a few years later with an upper gastrointestinal haemorrhage. Since he was not being followed at our clinic at that time, we did not know the exact cause. BuddChiari syndrome is a possibility. ZS was being closely followed for several years for very severe central nervous system involvement in the form of combined cerebral, cerebellar and brainstem involvement Finally, FS died reportedly of a cerebrovascular event which might or might not have been related to BS.
DISCUSSION
The rarity of the main survey outcome 'death' prompted us to make three adjustments in the analysis of our data. (A) In terms of calculating death on a per age basis, we grouped patients according to age intervals during which at least one death occurred. (B) Rather than calculating death within a year for each age bracket under consideration, we utilized a 10-yr horizon. (Q We deliberately chose two old foreign mortality tables which we would expect to have higher mortality rates so as to test our observed mortality under the 'worst case' conditions.
We realize that our observations are limited and the statistical assumptions would be theoretically more sound with more extended data, yet the results we obtained in the 15-24yr age bracket, we believe, are sufficiently important even with the sparse data at hand.
We failed to reach 32/152 (21%) of our initial study group and 17/92 (18%) of our male patients. The majority of these patients were people who lived in Istanbul, but who had changed their addresses without leaving new ones. There is very rapid urbanization with corresponding rebuilding in Turkey. In certain instances, whole blocks that had been the recorded addresses of the patients had been demolished and there were no neighbours to seek the new addresses from. This, we believe, is the main reason for our failing to reach the non-attenders. It is also seen that the disease severity among the group that we failed to reach tended not to be more pronounced, even when one focused on the youngest age bracket. Thus, we think that our observed mortality is probably close to the actual number. Strictly speaking, however, it must be called a 'minimum' mortality.
The male exclusiveness of our deceased patients and the significance observed in the youngest age bracket when compared with the three population tables are both in line with our and others' previous observations of more severe disease in the young and the male [1, 5] . We still do not know the cause behind this. It mandates, however, that we should closely follow the young male with BS and perhaps consider using prophylactic immunosuppressives once the diagnosis is made.
